Monoclonal Antibodies of Hybridomas

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1983 English Publisher:Oxford University Press (OUP)Journal:Clinical Infectious Diseases, volume 5, pages 9-34 (issn: 1058-4838, eissn: 1537-6591,

Copyright policy )

Authors: J G, Sinkovics; G R, Dreesman;

doi: 10.1093/clinids/5.1.9

pmid: 6298921

Monoclonal Antibodies of Hybridomas

- Summary
- Subjects
- Metrics

Abstract

Among the most prominent biological advances of this century, the hybridoma technology stands out as providing the best tool for the analysis of complex antigens of pathogens and tumor cells. This technology will play a major role in the immunodiagnosis and treatment of infectious and malignant diseases. This review focuses on the most recent developments (1980-1981), with emphasis on human immunology.

Related Organizations

Baylor University
United States
Baylor College of Medicine
United States

Keywords

Adult, Hybridomas, Leukemia, Leukemia, Experimental, Lymphoma, Carcinoma, Antibodies, Monoclonal, Mammary Neoplasms, Experimental, Sarcoma, Middle Aged, Leukemia Virus, Murine, Mice, Antigens, Neoplasm, Methods, Animals, Humans, Female, Melanoma

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	30
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%